Safety and immunogenicity of 2010-2011 H1N1/2009-containing trivalent inactivated influenza vaccine in children 12 to 59 months of age who received ASO3-Adjuvanted H1N1/2009 pandemic vaccine.

Joanne M. Langley, David W Scheifele, C. Quach, O. Vanderkooi, S. Dobson, Safety and immunogenicity of 2010-2011 H1N1/2009-containing trivalent inactivated influenza vaccine in children 12 to 59 months of age who received ASO3-Adjuvanted H1N1/2009 pandemic vaccine., J. Kellner, S. McNeil, D. MacKinnon-Cameron, B. Smith and Scott A Halperin